46. Díaz EM, Cordero MA. Nódulo de mama. Papel del médico general integral para su detección precoz mediante la enseñanza y el control del auto examen de mama. Rev Cubana Med Gen Integr 1999; 7(4):328-34.
47. Carter AC. Methods of motivating the practice of breast self-examination. A randomized trial. Prev Med 2003; 14(5):555-72.
48. Moreno LF, Pérez IM. Tratamiento del cáncer de mama. INOR 2005:4-10.
49. Ries LAG, Kosary CL, Hankey BF, et al, eds. SEER Cancer Statistics Review. 2004. Bethesda, MD: National Cancer Institute; 1999.
50. Spicer DV, Krecker EA, Pike MC. The endocrine prevention of breast cancer. Cancer Invest. 2006; 13:494-504.
51. Howe GM, ed. Global Geocancerology. New York, NY: Churchill-Livingstone; 1999
52. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 2000; 275:913-918.
53. Lerman C, Rimer BK, Engstrom PF. Cancer risk notification: psychological and ethical implications. J Clin Oncol. 2005;9: 1275-12
54. Black WC, Nease RF Jr, Tosteson ANA. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 2000; 87:720-731.
55. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat. 1999; 28:145-155.
56. Vogel VG. Counseling the high-risk woman. In: Stoll BA, ed. Reducing Breast Cancer Risk in Women. Boston, MA: Kluwer Academic Publishers; 2000:69-80.
57. Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 2006;87: 16
58. . Longnecker MP, Newcombe PA, Mittendorf R, et al. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst. 1999:87:923-929.
59. Colditz GA, Hankison SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 2000; 332: 1589-1593.
60. . Bernstein L, Pike MC, Ross RK, et al. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst. 2007; 74:741-745.
61. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer. N Engl J Med. 2006; 327:319-328.
62. Hunter DJ, Spiegelman D, Adami O, et al. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med. 2000; 334:356-361.
63. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1999;81:1879-1886.
64. Brody LC, Biesecker BB. Breast cancer susceptibility genes. BRCA1 and BRCA2. Medicine. 1998; 77:208-226.
65. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999; 340:77-84.
66. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998; 90:1371-1388.